Ludivine S. Breger - Publications

Lund University, Lund, Skåne län, Sweden 
Parkinson, animal model, a-syn, viral vector

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hoban DB, Shrigley S, Mattsson B, Breger LS, Jarl U, Cardoso T, Nelander Wahlestedt J, Luk KC, Björklund A, Parmar M. Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD. Proceedings of the National Academy of Sciences of the United States of America. PMID 32541058 DOI: 10.1073/Pnas.2001305117  0.55
2018 Quintino L, Avallone M, Brännstrom E, Kavanagh P, Lockowandt M, Garcia Jareño P, Breger LS, Lundberg C. GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration. Gene Therapy. PMID 30531868 DOI: 10.1038/S41434-018-0049-0  0.679
2018 Quintino L, Namislo A, Davidsson M, Breger LS, Kavanagh P, Avallone M, Elgstrand-Wettergren E, Isaksson C, Lundberg C. Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain. Molecular Therapy. Methods & Clinical Development. 11: 29-39. PMID 30324128 DOI: 10.1016/J.Omtm.2018.08.008  0.721
2018 Fieblinger T, Zanetti L, Sebastianutto I, Breger LS, Quintino L, Lockowandt M, Lundberg C, Cenci MA. Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. Scientific Reports. 8: 10068. PMID 29968767 DOI: 10.1038/S41598-018-28273-5  0.715
2017 Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Björklund A. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 28900002 DOI: 10.1073/Pnas.1710442114  0.559
2016 Breger LS, Kienle K, Smith GA, Dunnett SB, Lane EL. Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease. Brain, Behavior, and Immunity. PMID 27864045 DOI: 10.1016/J.Bbi.2016.11.014  0.73
2016 Chtarto A, Humbert-Claude M, Bockstael O, Das AT, Boutry S, Breger LS, Klaver B, Melas C, Barroso-Chinea P, Gonzalez-Hernandez T, Muller RN, DeWitte O, Levivier M, Lundberg C, Berkhout B, et al. A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Molecular Therapy. Methods & Clinical Development. 5: 16027. PMID 27069954 DOI: 10.1038/mtm.2016.27  0.67
2016 Breger L, Wettergren EE, Quintino L, Lundberg C. Regulated Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 1382: 57-66. PMID 26611578 DOI: 10.1007/978-1-4939-3271-9_4  0.691
2015 Humbert-Claude M, Chtarto A, Bockstael O, Breger L, Das A, De Witte O, Berkhout B, Lundberg C, Levivier M, Tenenbaum L. Toward the Pharmacological Control of Gene Transfer-Mediated Intracerebral Neurotrophic Factor Administration Journal of Neurological Surgery Part a: Central European Neurosurgery. 76. DOI: 10.1055/s-0035-1564510  0.634
2013 Breger LS, Lane EL. L-DOPA and graft-induced dyskinesia: different treatment, same story? Experimental Biology and Medicine (Maywood, N.J.). 238: 725-32. PMID 23828589 DOI: 10.1177/1535370213488478  0.785
2013 Breger LS, Dunnett SB, Lane EL. Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat. Neurobiology of Disease. 50: 142-50. PMID 23072976 DOI: 10.1016/J.Nbd.2012.10.013  0.76
2012 Smith GA, Breger LS, Lane EL, Dunnett SB. Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats. Neuropharmacology. 63: 818-28. PMID 22722025 DOI: 10.1016/J.Neuropharm.2012.06.011  0.73
Show low-probability matches.